| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |